Search results
Results From The WOW.Com Content Network
Naegleria fowleri, also known as the brain-eating amoeba, is a species of the genus Naegleria. It belongs to the phylum Percolozoa and is classified as an amoeboflagellate excavate , [ 1 ] an organism capable of behaving as both an amoeba and a flagellate .
[31] Drug treatment research at Aga Khan University in Pakistan has shown that in vitro drug susceptibility tests with some FDA approved drugs used for non-infectious diseases (digoxin and procyclidine were shown to be most effective of the drugs studied) have proved to kill Naegleria fowleri with an amoebicidal rate greater than 95%. [32]
Previously one could only get it from the CDC for emergency use under an expanded access IND protocol for treatment of free-living amoeba (FLA) infections: primary amoebic meningoencephalitis caused by Naegleria fowleri and granulomatous amoebic encephalitis caused by Balamuthia mandrillaris and Acanthamoeba species. [37]
For premium support please call: 800-290-4726 more ways to reach us
Virotherapy is a treatment using biotechnology to convert viruses into therapeutic agents by reprogramming viruses to treat diseases. There are three main branches of virotherapy: anti-cancer oncolytic viruses, viral vectors for gene therapy and viral immunotherapy.
In asymptomatic infections, the amoeba lives by eating and digesting bacteria and food particles in the gut, a part of the gastrointestinal tract. [9] It does not usually come in contact with the intestine itself due to the protective layer of mucus that lines the gut. Disease occurs when amoeba comes in contact with the cells lining the intestine.
A new study about cancer is providing a glimmer of hope. It says that by the year 2050, the disease will kill almost no one under the age of 80. Increased efforts to discover cancer treatments led ...
According to the American Cancer Society, "available scientific evidence does not support any claims that TT can cure cancer or other diseases". [41] Zoetron therapy – therapy based around a large electromagnetic device that emitted a weak field which, it was claimed, could kill cancer cells. Patients were charged US$15,000 up-front for ...